Aptevo Therapeutics Inc. (APVO) compared with its closest peers (BOLT, ACXP, ENVB, DRMA, PCSA). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | $7.19M | -0.3 |
| Acurx Pharmaceuticals, Inc. (ACXP) | $6.36M | -0.5 |
| Enveric Biosciences, Inc. (ENVB) | $6.36M | -0.1 |
| Dermata Therapeutics, Inc. (DRMA) | $5.67M | -0.3 |
| Processa Pharmaceuticals, Inc. (PCSA) | $5.67M | -0.3 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $5.60M | -1.0 |
| Pulmatrix, Inc. (PULM) | $5.42M | -1.6 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | $5.30M | — |
| Revelation Biosciences, Inc. (REVB) | $4.32M | -0.0 |
| FibroBiologics, Inc. Common Stock (FBLG) | $4.17M | -0.6 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
APVO overview · APVO earnings · APVO financials · APVO KPIs · APVO investor relations · APVO ownership · APVO filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.